section name header

Evidence summaries

Biphasic Versus Monophasic Oral Contraceptives

Side effects and efficacy may be similar in monophasic and biphasic contraceptive pills. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 1 trial of limited quality comparing a biphasic and monophasic preparation (Percival-Smith 1990). The study examined 533 user cycles of a biphasic pill (500 µg norethindrone/35 µg ethinyl estradiol for 10 days, followed by 1000 µg norethindrone/35 µg ethinyl estradiol for 11 days; Ortho 10/11) and 481 user cycles of a monophasic contraceptive pill (1500 µg norethindrone acetate/30 µg ethinyl estradiol daily; Loestrin). The study found no significant differences in intermenstrual bleeding, amenorrhea and study discontinuation due to intermenstrual bleeding between the biphasic and monophasic oral contraceptive pills.

Comment: The quality of evidence is downgraded by study limitations (no information on method of randomization or allocation concealment, high discontinuation rate after randomization) and sparse data.

    References

    • Van Vliet HA, Grimes DA, Helmerhorst FM, Schulz KF. Biphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev 2006;(3):CD002032 [Review content assessed as up-to-date: 3 May 2011]. [PubMed]

Primary/Secondary Keywords